The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1

ABSTRACT Shigella flexneri is a Gram-negative pathogen that invades the colonic epithelium and causes millions of cases of watery diarrhea or bacillary dysentery predominately in children under the age of 5 years in developing countries. The effector Shigella enterotoxin 2 (ShET2), or OspD3, is encoded by the sen or ospD3 gene on the virulence plasmid. Previous literature has suggested that ospD3 is in an operon downstream of the ospC1 gene, and expression of both genes is controlled by a promoter upstream of ospC1. Since the intergenic region is 328 bases in length and contains several putative promoter regions, we hypothesized the genes are independently expressed. Here we provide data that ospD3 and ospC1 are not co-transcribed and that OspC1 is not required for OspD3/ShET2 function. Most importantly, we identified strong promoter activity in the intergenic region and demonstrate that OspD3/ShET2 can be expressed and secreted independently of OspC1. This work increases our understanding of the synthesis of a unique virulence factor and provides further insights into Shigella pathogenesis.

[1]  C. Robinson,et al.  Figures and Tables for : Characterisation of Shigella Spa 33 and Thermotoga FliM / N reveals a new model for C-ring assembly in T 3 SS , 2016 .

[2]  B. Liu,et al.  Transcriptional adaptation of Shigella flexneri during adherence to epithelial cells , 2015, Journal of basic microbiology.

[3]  T. Farag,et al.  Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Mo-fei Li,et al.  Sil: A Streptococcus iniae Bacteriocin with Dual Role as an Antimicrobial and an Immunomodulator That Inhibits Innate Immune Response and Promotes S. iniae Infection , 2014, PloS one.

[5]  Timo K. Korhonen,et al.  Dancing to Another Tune—Adhesive Moonlighting Proteins in Bacteria , 2014, Biology.

[6]  A. Hachani,et al.  Spa13 of Shigella flexneri has a dual role: chaperone escort and export gate-activator switch of the type III secretion system. , 2014, Microbiology.

[7]  N. Thomson,et al.  RNA-seq analysis of the influence of anaerobiosis and FNR on Shigella flexneri , 2014, BMC Genomics.

[8]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[9]  D. Rasko,et al.  Characterization of Intracellular Growth Regulator icgR by Utilizing Transcriptomics To Identify Mediators of Pathogenesis in Shigella flexneri , 2013, Infection and Immunity.

[10]  A. Blocker,et al.  Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation , 2013, Molecular microbiology.

[11]  J. Nataro,et al.  Chromosomal and Plasmid-Encoded Factors of Shigella flexneri Induce Secretogenic Activity Ex Vivo , 2012, PloS one.

[12]  D. Rasko,et al.  Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure , 2012, Molecular microbiology.

[13]  E. Crabill,et al.  The Pseudomonas syringae HrpJ protein controls the secretion of type III translocator proteins and has a virulence role inside plant cells , 2012, Molecular microbiology.

[14]  P. Sansonetti,et al.  Characterization of the Promoter, MxiE Box and 5′ UTR of Genes Controlled by the Activity of the Type III Secretion Apparatus in Shigella flexneri , 2012, PloS one.

[15]  Brian Henderson,et al.  Bacterial Virulence in the Moonlight: Multitasking Bacterial Moonlighting Proteins Are Virulence Determinants in Infectious Disease , 2011, Infection and Immunity.

[16]  J. Nataro,et al.  Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells. , 2011, FEMS immunology and medical microbiology.

[17]  Olga K. Kamneva,et al.  Two promoters and two translation start sites control the expression of the Shigella flexneri outer membrane protease IcsP , 2011, Archives of Microbiology.

[18]  O. Homann,et al.  MochiView: versatile software for genome browsing and DNA motif analysis , 2010, BMC Biology.

[19]  A. Maurelli,et al.  Spa15 of Shigella flexneri Is Secreted through the Type III Secretion System and Prevents Staurosporine-Induced Apoptosis , 2009, Infection and Immunity.

[20]  V. Viswanathan,et al.  Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea , 2009, Nature Reviews Microbiology.

[21]  A. Maurelli,et al.  Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein , 2009, Molecular microbiology.

[22]  J. Urban,et al.  Anti-Inflammatory Mechanisms of Enteric Heligmosomoides polygyrus Infection against Trinitrobenzene Sulfonic Acid-Induced Colitis in a Murine Model , 2008, Infection and Immunity.

[23]  M. Goldberg,et al.  Differential Regulation by Magnesium of the Two MsbB Paralogs of Shigella flexneri , 2008, Journal of bacteriology.

[24]  Hubert Hilbi,et al.  Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion , 2008, Clinical Microbiology Reviews.

[25]  Dong Wook Kim,et al.  An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses , 2007, Nature Immunology.

[26]  A. Maurelli,et al.  OspF and OspC1 Are Shigella flexneri Type III Secretion System Effectors That Are Required for Postinvasion Aspects of Virulence , 2006, Infection and Immunity.

[27]  R. Pickersgill,et al.  Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. , 2005, Biochemical and biophysical research communications.

[28]  E. Denamur,et al.  Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. , 2005, Microbiology.

[29]  Hong Liu,et al.  Transcriptional Adaptation of Shigella flexneri during Infection of Macrophages and Epithelial Cells: Insights into the Strategies of a Cytosolic Bacterial Pathogen , 2005, Infection and Immunity.

[30]  P. Sansonetti,et al.  IL-8 Is a Key Chemokine Regulating Neutrophil Recruitment in a New Mouse Model of Shigella-Induced Colitis , 2004, The Journal of Immunology.

[31]  N. Verma,et al.  Shigella flexneri infection: pathogenesis and vaccine development. , 2004, FEMS microbiology reviews.

[32]  P. Sansonetti,et al.  Identification of the cis-Acting Site Involved in Activation of Promoters Regulated by Activity of the Type III Secretion Apparatus in Shigella flexneri , 2002, Journal of bacteriology.

[33]  A. Maurelli,et al.  MxiE Regulates Intracellular Expression of Factors Secreted by the Shigella flexneri 2a Type III Secretion System , 2002, Journal of bacteriology.

[34]  C. Buchrieser,et al.  The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri , 2000, Molecular microbiology.

[35]  A. Israël,et al.  Invasive Shigella flexneri Activates NF-κB Through a Lipopolysaccharide-Dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells1 , 2000, The Journal of Immunology.

[36]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Maurelli,et al.  Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium. , 1998, Infection and immunity.

[38]  P. Sansonetti,et al.  Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation , 1997, Infection and immunity.

[39]  M. Levine,et al.  Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. , 1997, Gut.

[40]  D. Maneval,et al.  Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains , 1995, Infection and immunity.

[41]  D. Maneval,et al.  Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. , 1995, The Journal of clinical investigation.

[42]  P. Sansonetti,et al.  Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. , 1994, The Journal of clinical investigation.

[43]  N. R. Kamini,et al.  Broad host range plasmids carrying the Escherichia coli lactose and galactose operons. , 1992, FEMS microbiology letters.

[44]  J. Mills,et al.  Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies , 1988, Infection and immunity.

[45]  A. Maurelli,et al.  Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid , 1984, Infection and immunity.

[46]  Jeffrey H. Miller.  Experiments in molecular genetics , 1972 .

[47]  S. Formal,et al.  EXPERIMENTAL SHIGELLA INFECTIONS: CHARACTERISTICS OF A FATAL INFECTION PRODUCED IN GUINEA PIGS , 1958, Journal of bacteriology.